Hye Jung Lim

Title: Hye Jung Lim: Innovator in Oral Solid Dosage Forms

Introduction

Hye Jung Lim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical formulations, particularly in oral solid dosage forms. With a total of 3 patents to his name, Lim's work focuses on improving the efficacy and usability of medications.

Latest Patents

One of Lim's latest patents is an oral solid dosage form composition that features an improved disintegration method. This composition includes an active ingredient and a solubilizing carrier, utilizing a foaming ingredient to enhance disintegration, dispersion, or dissolution. Another significant patent is for an oral tablet formulation of lenalidomide. This patent describes a tablet composition that exhibits physicochemical equivalence with lenalidomide preparations of hard capsules, ensuring the same pharmacological and therapeutic effects while improving ease of use and safety.

Career Highlights

Throughout his career, Hye Jung Lim has worked with prominent companies in the pharmaceutical industry, including Samyang Holdings Corporation and Samyang Biopharmaceuticals Corporation. His experience in these organizations has allowed him to develop innovative solutions that address critical needs in medication delivery.

Collaborations

Lim has collaborated with several professionals in his field, including Sang Yeob Park and Min Hyo Seo, who is a talented woman in the industry. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Hye Jung Lim's contributions to the field of oral solid dosage forms demonstrate his commitment to innovation in pharmaceuticals. His patents reflect a deep understanding of the challenges in medication formulation and a dedication to improving patient outcomes.